Therazymes Private Limited
Manufactures pharmaceuticals, chemicals, and botanical products for healthcare, research, and contract manufacturing.
2018 | Hyderabad, Telangana (India) | Active
Therazymes Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -19.86%
- Profit Growth -31.55%
- Ebitda -99.70%
- Net Worth 28.10%
- Total Assets -8.97%
About Therazymes
Therazymes Private Limited (TPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2018 (Six years and four months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dayakar Mallu and Sreenivasulu Mallu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304TG2018PTC127504
- Company No.
127504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Therazymes?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasulu Mallu  | Director | 09-Oct-2018 | Current |
Dayakar Mallu  | Additional Director | 11-Oct-2018 | Current |
Financial Performance of Therazymes.
Therazymes Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.86% decrease. The company also saw a substantial fall in profitability, with a 31.55% decrease in profit. The company's net worth Soared by an impressive increase of 28.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therazymes?
In 2022, Therazymes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Therazymes Pharmaceuticals Private Limited
Dayakar Mallu and Sreenivasulu Mallu are mutual person
- Vinta Laboratories Private Limited
Dayakar Mallu and Sreenivasulu Mallu are mutual person
- Lakshmi Infra Projects Llp
Sreenivasulu Mallu is a mutual person
- Castlestone Ventures Private Limited
Sreenivasulu Mallu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Therazymes?
Unlock and access historical data on people associated with Therazymes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therazymes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therazymes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
